The hepatitis b virus (hbv) global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Hepatitis B Virus (HBV) Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The hepatitis b virus (hbv) market size has grown rapidly in recent years. It will grow from $6.04 billion in 2023 to $6.71 billion in 2024 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rising prevalence of hepatitis b virus (hbv), growing demand for hbv diagnostics, expanding hbv vaccine coverage, rising awareness of hepatitis b virus (hbv).
The hepatitis b virus (hbv) market size is expected to see strong growth in the next few years. It will grow to $9.71 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to the rise of personalized medicine, growing support from patient advocacy groups, rising vaccination programs, increase in healthcare expenditure. Major trends in the forecast period include development of new drugs, advancements in diagnostic technologies, public-private partnerships, innovative biological therapies.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Market Drivers –
The high prevalence of hepatitis B infection is expected to propel the growth of the hepatitis B virus market going forward. Hepatitis B is a liver infection brought on by the hepatitis B virus (HBV), which is prevented through vaccination. Rising hepatitis B infection rates can increase demand for diagnostic tests and treatment options. For instance, in December 2022, according to the European Centre for Disease Prevention and Control, a Sweden-based agency for strengthening Europe’s defenses against infectious diseases, hepatitis B virus (HBV) infection was recorded in 16,187 cases in 30 Eastern European Member States in 2021. Further, the total cases 15,380 equal a crude rate of 4.7 cases per 100,000 people, compared to 14,332 in 2020. Therefore, the high prevalence of hepatitis B infection will drive the hepatitis B virus market.
Market Trends –
Major companies operating in the hepatitis B virus (HBV) market are focused on the development of advanced diagnostics and treatment options such as the use of highly sensitive chemiluminescent microparticle immunoassay (CMIA) to gain competitive advantages in the market. For instance, in May 2022, Abbott Laboratories, a US-based healthcare company, launched the HBsAg Next Qualitative Solution Test, which will aid in the early detection of Hepatitis B virus (HBV) in human serum and plasma samples and improve patient outcomes while preserving safe blood supplies. The early and improved detection of HBV in human serum and plasma (blood) samples, as well as population screening, are made possible by this highly sensitive chemiluminescent microparticle immunoassay (CMIA).
The hepatitis b virus (hbv) market covered in this report is segmented –
1) By Type: Acute; Chronic
2) By Treatment: Immune Modulator Drugs; Antiviral Drugs; Vaccine; Surgery
3) By Age Group: Pediatrics; Adults; Seniors
4) By End User: Medical Providers; Patients; Healthcare Payers
Get an inside scoop of the hepatitis b virus (hbv) market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=12867&type=smp
Regional Insights –
North America was the largest region in the hepatitis B Virus (HBV) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hepatitis B virus (HBV) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Key Companies –
Major players in the hepatitis b virus (hbv) market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmon La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Sanofi SA, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Boehringer Ingelheim International GmbH, Mylan N.V., Teva Pharmaceutical Industries Ltd., Vertex Pharmaceuticals Incorporated, Eisai Co. Ltd., Aurobindo Pharma Limited, Apotex Corp., Lupin Pharmaceuticals Inc., Cadila Healthcare Ltd., Celltrion Inc., Dynavax Technologies Corporation, Accord Healthcare Inc., Par Pharmaceutical Inc., Arrowhead Pharmaceuticals Inc., Arbutus Biopharma Corporation, Globeimmune Inc., Antios Therapeutics Inc.
Table of Contents
1. Executive Summary
2. Hepatitis B Virus (HBV) Market Report Structure
3. Hepatitis B Virus (HBV) Market Trends And Strategies
4. Hepatitis B Virus (HBV) Market – Macro Economic Scenario
5. Hepatitis B Virus (HBV) Market Size And Growth
…..
27. Hepatitis B Virus (HBV) Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
